Prof. Mai Haiqiang, was born in January 1973. He is a professor, chief physician, director of Department of Nasopharyngeal Carcinoma, doctoral advisor, a member of the Editorial Board of Chinese Journal of Cancer, a member of Committee of Nasopharyngeal Cancer under Chinese Anti-Cancer Association, an evaluation expert of National Natural Science Foundation of China and a special reviewer for BMC Cancer and Tumor Biology. He specializes in nasopharyngeal carcinoma early diagnosis, individualized combination therapy, curative effect prediction and prognosis studies.

Nasopharyngeal carcinoma early diagnosis, individualized combination therapy, curative effect prediction and prognosis study

09/1991-06/1998  Seven-Year Master Program of Clinical Medicine, former Sun Yat-sen University of Medical Sciences

09/2002-06/2005  MD at Sun Yat-sen University

Publications as the first author or corresponding author (*, a mark of corresponding author):

1. Zhang L, Chen QY, Liu H, Tang LQ, Mai HQ*. Emerging treatment options for nasopharyngeal carcinoma. Drug Des Devel Ther. 2013;7:37-52.

2. Liu H, Chen QY, Guo L, Tang LQ, Mo HY, Zhong ZL, Huang PY, Luo DH, Sun R, Guo X, Cao KJ, Hong MH, Mai HQ*.Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis. Radiat Oncol. 2013;8(1):70.

3. Huang PY, Wang CT, Cao KJ, Guo X, Guo L, Mo HY, Wen BX, Wu YS, Mai HQ*, Hong MH. Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial. Eur J Cancer. 2013 Feb 21. [Epub ahead of print]

4. Mo HY, Sun R, Sun J, Zhang Q, Huang WJ, Li YX, Yang J, Mai HQ*. Prognostic value of pretreatment and recovery duration of cranial nerve palsy in nasopharyngeal carcinoma. Radiat Oncol. 2012;7(1):149.

5. Mo HY, Luo DH, Qiu HZ, Liu H, Chen QY, Tang LQ, Zhong ZL, Huang PY, Zhao ZJ, Zhang CQ, Zhang Y, Mai HQ*. Elevated serum endostatin levels are associated with poor survival in patients with advanced-stage nasopharyngeal carcinoma. Clin Oncol. 2013 Jan 2. [Epub ahead of print]

6. Huang PY, Sun ZY, Xie CM, Chen QY, Wen YF, Li J, Qiu HZ, Liu H, Zhong ZL, Mai HQ*, Mo HY. Prognostic significance of the various classifications for parapharyngeal space involvement in nasopharyngeal carcinoma. Acta Otolaryngol. 2012;132(11):1197-1207.

7. Li SX, Chen QY, Zhang YJ, Liu ZM, Xiong HL, Guo ZY, Mai HQ*, Liu SH. Detection of nasopharyngeal cancer using confocal Raman spectroscopy and genetic algorithm technique. J Biomed Opt. 2012;17(12):125003.

8. Huang PY, Cao KJ, Guo X, Mo HY, Guo L, Xiang YQ, Deng MQ, Qiu F, Cao SM, Guo Y, Zhang L, Li NW, Sun R, Chen QY, Luo DH, Hua YJ, Mai HQ*, Hong MH. A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Oral Oncol. 2012;48(10):1038-1044.

9. Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, Li NW, Xiang YQ, Luo DH, Qiu F, Sun R, Deng MQ, Chen MY, Hua YJ, Guo X, Cao KJ, Hong MH, Qian CN, Mai HQ*. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst. 2011;103(23):1761-1770.

10. Wen YF, Qi B, Liu H, Mo HY, Chen QY, Li J, Huang PY, Ye YF, Zhang Y, Deng MQ, Guo X, Hong MH, Cao KJ, Mai HQ*.Polymorphisms in the endothelin-1 and endothelin a receptor genes and survival in patients with locoregionally advanced nasopharyngeal carcinoma. Clin Cancer Res. 2011;17(8):2451-2458.

11. Mai HQ, Mo HY, Deng JF, Deng MQ, Mai WY, Huang XM, Guo X, Hong MH. Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma. Eur J Cancer. 2009;45(7):1107-1110.

12. Mai HQ, Zeng ZY, Feng KT, Ye YL, Zhang CQ, Liang WJ, Guo X, Mo HY, Hong MH. Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma. Cancer Sci. 2006;97(12):1388-1395.

13. Mai HQ, Zeng ZY, Zhang CQ, Feng KT, Guo X, Mo HY, Deng MQ, Min HQ, Hong MH. Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma. Cancer. 2006;106(7):1548-1553.

14. Mai HQ, May WS, Gao F, Jin Z, Deng X. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem. 2003;278(3):1886-1891.

15. Mai HQ, Xu LH, Liu H, Mo HY, Huang PY, Tang LQ, Chen QY. Endothelin-1 promotes 6-10B nasopharyngeal carcinoma cell migration by inducing the expression of chemokine receptor CXCR4. Journal of Sun Yat-sen University (Medical Sciences). 2011;32(5):616-622.

16. Qi B, Guo X, Wen YF, Mo HY, Chen QY, Liu H, Li J, Ye YF, Mai HQ*. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in locoregionally advanced nasopharyngeal carcinoma. Chinese Journal of Cancer Prevention and Treatment. 2010;17(10): 755-758.

17. Chen QY, Zhang CQ, Mo HY, Deng MQ, Cao SM, Hong MH, Guo X, Mai HQ*. Dynamic changes of serum VEGF of nasopharyngeal carcinoma patients during radiotherapy. Chinese Journal of Cancer Prevention and Treatment. 2009;16(18):1424-1426.

18. Huang WJ, Mo HY, Deng MQ, Mai HQ*, Qi B, Li J, Hong MH, Guo X. Relationship between cranial nerve involvement in nasopharyngeal carcinoma and the prognosis. Journal of Clinical Otorhinolaryngology Head and Neck Surgery. 2009;23(21):964-967.

19. Qi B, Guo X, Wen YF, Mo HY, Chen QY, Liu H, Li J, Ye YF, Mai HQ*. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in locoregionally advanced nasopharyngeal carcinoma. Chinese Journal of Cancer Prevention and Treatment. 2010;17(10):755-758.

20. Chen QY, Zhang CQ, Mo HY, Deng MQ, Cao SM, Hong MH, Guo X, Mai HQ*. Dynamic changes of serum VEGF of nasopharyngeal carcinoma patients during radiotherapy. Chinese Journal of Cancer Prevention and Treatment. 2009;16(18):1424-1427.

21. Huang WJ, Mo HY, Deng MQ, Mai HQ*, Qi B, Li J, Hong MH, Guo X. Relationship between cranial nerve involvement in nasopharyngeal carcinoma and the prognosis. Journal of Clinical Otorhinolaryngology Head and Neck Surgery. 2009;23(21):964-967.

22. Deng MQ, Mai HQ*, Mai WY, Mo HY, Huang XM, Guo X, Hong MH. Endoscopic microwave coagulation therapy for locally recurrent nasopharyngeal carcinoma. Chinese Journal of Cancer. 2008; 27(7):734-737.

23. Zhao ZJ, Mo HY, Zhang CQ, Qi B, Li J, Hong MH, Mai HQ*. Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma. Chinese Journal of Cancer. 2007;26(11):1243-1247.

24. Mai HQ, Zeng ZY, Zhang HZ, Hou JH, Mo HY, Guo X,Min HQ, Hong MH. Correlation of endothelin a receptor expression to prognosis of nasopharyngeal carcinoma. Chinese Journal of Cancer. 2005;24(5):611-615.

25. Mai HQ, Mo HY, Hong MH, Guo X, Deng MQ, Zhang F, Min HQ. Impact of pre-radiotherapy hemoglobin level on local control of nasopharyngeal carcinoma. Chinese Journal of Cancer. 2005;24(6):89-92.

26. Ma J, Mai HQ*, Hong MH, Mo HY, Cui NJ, Lu TX, Min HQ. Clinical evaluation of 1997 UICC staging system for nasopharyngeal carcinoma. Chinese Journal of Cancer. 2001;20(3):301-304.

27. Mai HQ, Huang XM, Zhang F, Deng MQ, Guo X, Min HQ. Clinical analysis on osteoradionecrosis of skull base in patients with nasopharyngeal carcinoma after radiotherapy. Chinese Journal of Cancer. 2001;20(1):69-71.

28. Mai HQ, Ma J, Zhang JM, Huang TB, Mo YX. Effect of computed tomography on N-staging for nasopharyngeal carcinoma. Chinese Journal of Cancer. 2000;19(9):907-910.

29. Ma J, Mai HQ*, Mo HY, Lu TX, Cui NJ, Hong MH. Patterns of treatment failure after primary radiotherapy in patients with nasopharyngeal carcinoma. Chinese Journal of Cancer. 2000;19(11):1016-1018.

Edited Works:

1. Mai HQ. ‘Endoscopy and Differential Diagnosis’, in Min HQ, Hong MH, Guo X, Nasopharyngeal Carcinoma. Beijing: China Medical Science Press. 2003;Edition 1:101-114.

2. Mai HQ. ‘Prognosis and Prognostic Factors’, in Min HQ, Hong MH, Guo X, Nasopharyngeal Carcinoma. Beijing: China Medical Science Press. 2003;Edition 1:379-397.

3. Mai HQ (Editorial Board Member). ‘Nasopharyngeal Carcinoma’, in International Comparative Study on the Scientific and Technological Innovation Ability of Chinese Modern Medicine, organized by China National Center for Biotechnology Development. Beijing: China Medical Science Press. 2009.

4. Mai HQ, Huang WL (Eds). Biopharmaceutical “Miracles” -- The Birth and Development of Gene Medicine. Guangzhou: Guangdong Science and Technology Press. 2011.

5. Mai HQ (Editorial Board Member). ‘Nasopharyngeal Carcinoma’, in A Course in Advanced Clinical Oncology. Beijing: People’s Military Medical Press. 2011.

6. Mai HQ (Subeditor). Diagnosis and Treatment of Nasopharyngeal Carcinoma. World Publishing Corporation. 2012.

Honors and Awards:

1. 2012 The 3rd Guangdong Science and Technology Innovation Excellent Academic Papers First Prize

2. 2012 The Seventh Batch of Provincial Talents for Guangdong “Ten-Hundred-Thousand” Project

3. 2011 Ministry of Education Program for New Century Excellent Talents in University

4. 2009 Dr. Cheng Yu Tung Fellowships awarded by the Li Ka Shing Faculty of Medicine at the University of Hong Kong

5. 2009 The second National Prize for Progress in Science and Technology with “Research and Application of Comprehensive Treatment of Nasopharyngeal Carcinoma Based on Modern Imaging Technology” (the fourth author)

6. 2008 The 5th “Ten Outstanding Young Persons of Yunfu City”

7. 2008 The first Guangdong Provincial Science and Technology Award with “Research of Comprehensive Treatment of Nasopharyngeal Carcinoma Based on Modern Imaging Technology” (the fourth author)

8. 2008 The second Prize for Progress in Science and Technology of Ministry of Education with “Research of Comprehensive Treatment of Nasopharyngeal Carcinoma Based on Imaging ” (the fourth author)

9. 2007 The first Science and Technology Award of Chinese Medical Association with “Research of Comprehensive Treatment of Nasopharyngeal Carcinoma Based on Modern Imaging Technology” (the fourth author)

10. 2007 “Cancer Science Young Scientists Award” of Japanese Cancer Association

Updated by International Office, Sun Yat-sen University Cancer Center